Enter your login e-mail to the account
Search
- The choice of antidiabetic medications with regard to metabolic syndrome
doc. MUDr. Alena Šmahelová, PhD.
(11/2009, Review articles ) - GLITAZONES – PAST, PRESENT AND FUTURE
PharmDr. Tomáš Tesař, PhD., MBA, MUDr. Adriana Ilavská
(9/2008, clearly ) - The management of non-alcoholic fatty liver disease
prof. MUDr. Jozef Holomáň, CSc., doc. MUDr. Mária Szántová, PhD., Doc. MUDr. Martin Zima, PhD., PharmDr. Ľubica Slobodová
(5/2016, Topic of the year ) - NONALCOHOLIC FATTY LIVER DISEASE
MUDr. Martin Zima, PhD.
(4-5/2008, Topic ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - METABOLIC SYNDROME, CARDIOVASCULAR AND METABOLIC RISK
prof. MUDr. Peter Galajda, CSc.
(S4/2007, Supplement ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - Therapy of acute phase and secondary prevention of ischaemic stroke and transient ischaemic attack – changes after the publication of the ESO 2008 and 2009 guidelines
doc. MUDr. Roman Herzig, Ph.D., FESO
(S3/2010, Supplement ) - Risk perceptions in the antiaggregation preventive therapy
MUDr. Ewald Ambrózy, prof. MUDr. Andrej Dukát, CSc., prof. MUDr. Milan Kriška, DrSc., MUDr. Ján Kriška, MUDr. Ján Rajec, PhD., prof. MUDr. Ján Gajdošík, PhD.
(S3/2010, Supplement ) - THERAPY OF OBESE PATIENTS WITH DIABETES MELLITUS
doc. MUDr. Boris Krahulec, CSc., MUDr. Daša Habdáková
(12/2005, Topic ) - Weight loss pharmacotherapy of obese non-diabetic and type 2 diabetic patients
MUDr. Ľubomíra Fábryová, PhD.
(6/2015, Topic of the year ) - Sitagliptine – representative of the new group of drugs indicated in the treatment of type 2 diabetes mellitus
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(4/2010, Drugs & drug classes ) - INCRETIN-BASED THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(7-8/2008, Topic ) - WEIGHT MANAGEMENT FOR OBESE TYPE 2 DIABETICS
MUDr. Ľubomíra Fábryová, PhD.
(7-8/2008, Topic ) - Effective drug therapy of liver diseases in general practice
doc. MUDr. Radan Brůha, CSc.
(1/2014, Review articles )
- Therapy of acute phase and secondary prevention of ischaemic stroke and transient ischaemic attack – changes after the publication of the ESO 2008 and 2009 guidelines
doc. MUDr. Roman Herzig, Ph.D., FESO
(5/2009, Review articles ) - Alzheimer’s disease and type 2 diabetes mellitus
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(2/2012, From the boundary of neurology )
- Perorální antidiabetika – současnost
prof. MUDr. Jindřiška Perušičová, DrSc.
(1/2009, Drugs & drug classes )
- The 42nd Days of Pharmacy with main topic „Diabetes“ – epidemic of the third millennium
doc. RNDr. Magdaléna Fulmeková, CSc.
(2/2016, Events )